Blood Preparation Market Is Predicted To Grow Quickly Due To Growing Worldwide Demand For Transfusion Of Blood Till 2022: Grand View Research, Inc.

Global Blood preparation Market is expected to reach USD 58.69 billion by 2022, according to a new study by Grand View Research, Inc. Growing worldwide demand for transfusion of blood and its components and increasing prevalence of blood-related disorders are expected to fuel the growth of the blood preparation market over the forecast period. The worldwide prevalence of thrombocytosis-associated disorders is steeply increasing. 

According to the Center for Disease control and Prevention (CDC), one to two people per 1,000 are affected by DVT/PE in the U.S. each year, and 60,000-100,000 Americans die due to DVT/PE. Commercialization of drugs currently in the pipeline, introduction of new oral anticoagulants, and the presence of large untapped opportunities are expected to boost product demand by triggering the incidence rates of target diseases.

Anticoagulants was the largest product segment in 2014 owing to, the increasing R&D aimed at the the development of novel prophylactic and therapeutic drugs. Re-launch of some key drug products such as Urokinase in North America is most likely expected to boost market growth over the forecast period. Microbix Biosystems Inc. acquired Urokinase from Abbott Laboratories (Abbokinase) to relaunch it as Kinelytic in the U.S. The drug is under regulatory approval and is expected to be relaunched in the middle of 2015 in the U.S.

Browse full research report on Blood Preparation Market: http://www.grandviewresearch.com/industry-analysis/blood-preparation-market

Further key findings from the study suggest:

  • The blood derivates market was valued at over 13.0 billion in 2014 and is expected grow at a lucrative rate from 2015 to 2022 owing to, the increasing transfusion needs of blood and its components. Increasing number of R&D pertaining to the development of blood-derived medicines and expected commercialization of new drugs are also expected to serve as high impact rendering drivers.
  • The direct factor Xa inhibitors market is identified as the most lucrative segment on account of the introduction of new oral products such as Xarelto, Savaysa, and Eliquis, targeting unmet medical needs.
  • The North American blood preparation market was the largest in 2014. The presence of sophisticated healthcare infrastructure and high patient awareness levels coupled with relatively higher healthcare expenditure levels in the region are some factors attributing to its market position.
  • Asia Pacific is anticipated to witness high future growth over the forecast period, owing to the presence of favorable government initiatives, sophisticated healthcare infrastructure in Japan and Australia and large untapped opportunities in the emerging markets of China and India.
  • Key players of the blood preparation market include GlaxoSmithKline PLC, Pfizer Inc., Baxter Healthcare Corp., Bristol-Myers Squibb Co., Leo Pharma Inc., Sanofi Aventis, AstraZeneca Co., and Celgene Corp.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global blood preparation market on the basis of products, anti-thrombotics and anticoagulant type, anti-thrombotics and anticoagulant application, and region:

Global Blood preparation Market Product Outlook (Revenue, USD Million, 2012 - 2022)
  • Whole Blood
    • Red Cells
    • Granulocytes
    • Plasma
    • Platelets
  • Blood Components
    • Whole Blood Components
    • Packed Red Cells
    • Leukocyte Reduced Red Blood Cells
    • Frozen Plasma
    • Platelet Concentrate
  • Blood Derivatives
Global Blood Preparation Market Anti-Thrombotic and Anticoagulants Type Outlook (Revenue, USD Million, 2012 - 2022)
  • Platelet Aggregation Inhibitors
    • Glycoprotein Inhibitors
    • COX Inhibitors
    • ADP Antagonists
    • Phosphodiesterase Inhibitors
  • Fibrinolytics
    • Tissue Plasminogen Activator (tPA)
    • Streptokinase
    • Urokinase
  • Anticoagulants
    • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
Global Blood Preparation Market Anti -Thrombotic and Anticoagulants Application Outlook (Revenue, USD Million, 2012 - 2022)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Others
Blood preparation Market Regional Outlook (Revenue, USD Million, 2012 - 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa
Ant-ithrombotics and Anticoagulants Regional Outlook (Revenue, USD Million, 2012 - 2022)
  • North America
    • U.S.
    • Canada
  •  Europe
    • Germany
    • France
    • UK
    • Italy
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more